A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EFINOPEGDUTIDE (MK-6024) IN ADULTS WITH PRECIRRHOTIC NONALCOHOLIC STEATOHEPATITIS

Registry ID
MK-6024-013
Source registry
HEALTH_CANADA
Status
Ongoing
Phase
PHASE2
Study type
INTERVENTIONAL
Sponsor
MERCK CANADA INC
Start date
2024-01-16
Last update
2023-05-30

Conditions

Related clinical trials

View on source registry